1. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
- Author
-
Instituto de Salud Carlos III, European Commission, Fundación Científica Asociación Española Contra el Cáncer, Cancer Research UK, Fondazione Italiana per la Ricerca sul Cancro, Multiple Myeloma Research Foundation, European Hematology Association, European Research Council, Leukemia & Lymphoma Society (US), Bristol-Myers Squibb, Fondazione Regionale per la Ricerca Biomedica, Botta, Cirino, Pérez, Cristina, Larrayoz, Marta, Puig, Noemi, Cedena, Maria-Teresa, Termini, Rosalinda, Goicoechea, Ibai, Rodriguez, Sara, Zabaleta, Aintzane, López, Aitziber, Sarvide, Sarai, Blanco, Laura, Papetti, Daniele M., Nobile, Marco S., Besozzi, Daniela, Gentile, Massimo, Correale, Pierpaolo, Siragusa, Sergio, Oriol, Albert, González García, María-Esther, Sureda, Anna, Arriba, Felipe de, Ríos Tamayo, Rafael, Moraleda, José María, Gironella, Mercedes, Hernández, Miguel T., Bargay, Joan, Palomera, Luis, Pérez-Montaña, Albert, Goldschmidt, Hartmut, Avet-Loiseau, Hervé, Roccaro, Aldo, Orfao, Alberto, Martínez-López, Joaquín, Rosiñol, Laura, Lahuerta, Juan José, Bladé, Joan, Mateos, Maria Victoria, San-Miguel, Jesús, Martínez-Climent, José Ángel, Paiva, Bruno, Instituto de Salud Carlos III, European Commission, Fundación Científica Asociación Española Contra el Cáncer, Cancer Research UK, Fondazione Italiana per la Ricerca sul Cancro, Multiple Myeloma Research Foundation, European Hematology Association, European Research Council, Leukemia & Lymphoma Society (US), Bristol-Myers Squibb, Fondazione Regionale per la Ricerca Biomedica, Botta, Cirino, Pérez, Cristina, Larrayoz, Marta, Puig, Noemi, Cedena, Maria-Teresa, Termini, Rosalinda, Goicoechea, Ibai, Rodriguez, Sara, Zabaleta, Aintzane, López, Aitziber, Sarvide, Sarai, Blanco, Laura, Papetti, Daniele M., Nobile, Marco S., Besozzi, Daniela, Gentile, Massimo, Correale, Pierpaolo, Siragusa, Sergio, Oriol, Albert, González García, María-Esther, Sureda, Anna, Arriba, Felipe de, Ríos Tamayo, Rafael, Moraleda, José María, Gironella, Mercedes, Hernández, Miguel T., Bargay, Joan, Palomera, Luis, Pérez-Montaña, Albert, Goldschmidt, Hartmut, Avet-Loiseau, Hervé, Roccaro, Aldo, Orfao, Alberto, Martínez-López, Joaquín, Rosiñol, Laura, Lahuerta, Juan José, Bladé, Joan, Mateos, Maria Victoria, San-Miguel, Jesús, Martínez-Climent, José Ángel, and Paiva, Bruno
- Abstract
Tumor recognition by T cells is essential for antitumor immunity. A comprehensive characterization of T cell diversity may be key to understanding the success of immunomodulatory drugs and failure of PD-1 blockade in tumors such as multiple myeloma (MM). Here, we use single-cell RNA and T cell receptor sequencing to characterize bone marrow T cells from healthy adults (n = 4) and patients with precursor (n = 8) and full-blown MM (n = 10). Large T cell clones from patients with MM expressed multiple immune checkpoints, suggesting a potentially dysfunctional phenotype. Dual targeting of PD-1 + LAG3 or PD-1 + TIGIT partially restored their function in mice with MM. We identify phenotypic hallmarks of large intratumoral T cell clones, and demonstrate that the CD27− and CD27+ T cell ratio, measured by flow cytometry, may serve as a surrogate of clonal T cell expansions and an independent prognostic factor in 543 patients with MM treated with lenalidomide-based treatment combinations.
- Published
- 2023